HEC96719

DRUG3 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Non-Alcoholic SteatohepatitisNon-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNonalcoholic Steatohepatitis (NASH)

Phase 1

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects

CompletedNCT04422496

Sunshine Lake Pharma Co., Ltd.Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis

Start: 2020-08-10End: 2021-02-23Updated: 2021-05-07

Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

CompletedNCT04546984

Sunshine Lake Pharma Co., Ltd.Nonalcoholic Steatohepatitis (NASH)

Start: 2020-09-14End: 2020-12-29Updated: 2021-05-07

Phase 2

A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

CompletedNCT05397379

Sunshine Lake Pharma Co., Ltd.Non-Alcoholic Steatohepatitis

Start: 2021-11-15End: 2023-09-05Updated: 2024-02-21